Zp/Czd/052/26 Supply Of Medicinal Products And Provision Of Repackaging And Labeling Services For Medicinal Products Containing Everolimus, Together With Their Release For Use In The Non-Commercial Medway Clinical Trial "Phase I Study On The Use Of The Cdk8 Inhibitor Rvu120 In Combination With Everolimus In Children With Recurrent Or Progressive Group 3 Or 4 Medulloblastoma"